WO2020231030A3 - Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women - Google Patents
Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women Download PDFInfo
- Publication number
- WO2020231030A3 WO2020231030A3 PCT/KR2020/005262 KR2020005262W WO2020231030A3 WO 2020231030 A3 WO2020231030 A3 WO 2020231030A3 KR 2020005262 W KR2020005262 W KR 2020005262W WO 2020231030 A3 WO2020231030 A3 WO 2020231030A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formication
- nervousness
- vertigo
- insomnia
- fatigue
- Prior art date
Links
- 206010017062 Formication Diseases 0.000 title abstract 4
- 240000001046 Lactobacillus acidophilus Species 0.000 title abstract 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 title abstract 4
- 206010029216 Nervousness Diseases 0.000 title abstract 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title abstract 4
- 208000012886 Vertigo Diseases 0.000 title abstract 4
- 206010016256 fatigue Diseases 0.000 title abstract 4
- 206010022437 insomnia Diseases 0.000 title abstract 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 title abstract 4
- 208000035824 paresthesia Diseases 0.000 title abstract 4
- 231100000889 vertigo Toxicity 0.000 title abstract 4
- 235000013305 food Nutrition 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a composition comprising Lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women. As a result of applying Lactobacillus acidophilus YT1 strain according to the present invention to a food which is consumed by the human body, it was observed that nervousness, formication, insomnia, vertigo, or fatigue was alleviated in menopausal women who had taken a food containing the strain. Therefore, the composition comprising the Lactobacillus acidophilus according to the present invention is expected to be advantageously applied to the treatment, alleviation, or treatment of nervousness, formication, insomnia, vertigo, or fatigue in menopausal women.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2019-0056539 | 2019-05-14 | ||
KR1020190056539A KR102317304B1 (en) | 2019-05-14 | 2019-05-14 | Composition for preventing, improving, or treating of hypersensitivity, ant hallucination, insomnia, dizziness, or tiredness of menopausal female comprising Lactobacillus acidophilus |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2020231030A2 WO2020231030A2 (en) | 2020-11-19 |
WO2020231030A3 true WO2020231030A3 (en) | 2021-02-04 |
Family
ID=73289644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/005262 WO2020231030A2 (en) | 2019-05-14 | 2020-04-21 | Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102317304B1 (en) |
WO (1) | WO2020231030A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022169254A1 (en) * | 2021-02-03 | 2022-08-11 | 국민대학교 산학협력단 | Composition for preventing, alleviating or treating sleep disorders, containing, as active ingredient, gut microbiota or extracellular vesicles derived therefrom |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100016101A (en) * | 2007-03-30 | 2010-02-12 | 산토리 홀딩스 가부시키가이샤 | Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
US20110236358A1 (en) * | 2008-12-12 | 2011-09-29 | Stefano Sala | Composition comprising isoflavones |
KR20170028486A (en) * | 2015-09-03 | 2017-03-14 | 호서대학교 산학협력단 | Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient |
KR20180018422A (en) * | 2016-08-12 | 2018-02-21 | 한국식품연구원 | Composition for preventing or treating of climacterium comprising Lactobacillus acidophilus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101845245B1 (en) * | 2016-04-05 | 2018-04-04 | (주)아모레퍼시픽 | Composition for improving woman menopause symptom comprising extract of Sasa quelpaertensis Nakai |
-
2019
- 2019-05-14 KR KR1020190056539A patent/KR102317304B1/en active IP Right Grant
-
2020
- 2020-04-21 WO PCT/KR2020/005262 patent/WO2020231030A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100016101A (en) * | 2007-03-30 | 2010-02-12 | 산토리 홀딩스 가부시키가이샤 | Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
US20110236358A1 (en) * | 2008-12-12 | 2011-09-29 | Stefano Sala | Composition comprising isoflavones |
KR20170028486A (en) * | 2015-09-03 | 2017-03-14 | 호서대학교 산학협력단 | Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient |
KR20180018422A (en) * | 2016-08-12 | 2018-02-21 | 한국식품연구원 | Composition for preventing or treating of climacterium comprising Lactobacillus acidophilus |
Non-Patent Citations (1)
Title |
---|
EUN YEONG LIM; JAE GOO KIM; SUN YOUNG JUNG; EUN-JI SONG; SO-YOUNG LEE; HEE SOON SHIN; YOUNG-DO NAM; YUN TAI KIM: "Attenuating Effects of Lactobacillus acidophilus YT1 on Menopausal Symptoms in Ovariectomized Rats", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 47, no. 12, 1 January 2018 (2018-01-01), pages 1225 - 1233, XP009525589, ISSN: 2288-5978, DOI: 10.3746/jkfn.2018.47.12.1225 * |
Also Published As
Publication number | Publication date |
---|---|
KR102317304B1 (en) | 2021-10-26 |
WO2020231030A2 (en) | 2020-11-19 |
KR20200131657A (en) | 2020-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201701460B (en) | Gamma-diketones for treatment and prevention of aging skin and wrinkles | |
MX2023003416A (en) | Novel lactic acid bacteria and use thereof. | |
WO2018084531A3 (en) | Composition for prevention or treatment of bone disease, obesity, and lipid-related metabolic disorder | |
MX2012013787A (en) | Compositions and methods for stimulating magp-1 to improve the appearance of skin. | |
WO2013002584A3 (en) | Combination of effective substances causing synergistic effects of multiple targeting and use thereof | |
MX2021016034A (en) | Compositions and methods of treating a th2-mediated condition using prevotella. | |
MX2012000034A (en) | Methods for treating or preventing fatigue. | |
MX2018002507A (en) | Method for inhibiting absorption of and/or promoting excretion of lipids using d-psicose. | |
SG11202111168UA (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | |
WO2019045287A3 (en) | Composition comprising fraction of rosa multiflora extract as effective ingredient for preventing, alleviating, or treating immune disease | |
WO2020231030A3 (en) | Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women | |
MX2020008991A (en) | Methods for altering body composition. | |
EE05799B1 (en) | Composition comprising hypocholesterolemic probiotic microorganism strain Lactobacillus plantarum Inducia DSM 21379 for use in preventing cardiovascular disorders | |
CR20220570A (en) | Compositions comprising nanoparticles, method of making and uses thereof | |
PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
PH12020551071A1 (en) | Compositions and methods for treating retinal disorders | |
PL2224820T3 (en) | Comestible products | |
MX2018004783A (en) | Cosmetic composition imparting a natural complexion and a healthy-looking appearance effect. | |
GEP20207089B (en) | Histamine-producing bacterial strains and their use in cancer | |
WO2020231031A3 (en) | Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating arthromyalgia, headaches, or vaginal dryness in climacteric women | |
WO2018074862A3 (en) | Pharmaceutical composition comprising tha as active ingredient for treating breast cancer | |
WO2019059668A3 (en) | Composition for skin, containing, as active ingredient, milk cream liquid fermented by lactic acid bacteria | |
MX2022010868A (en) | Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin d deficiency, and disorders associated therewith. | |
GB2465939A (en) | Atopy cure baby dry milk with green tea and lactobacillus | |
MX2021011999A (en) | Dextran sulfate for inflammatory skin conditions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20805511 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20805511 Country of ref document: EP Kind code of ref document: A2 |